Prahsys Appoints Dr. Edward Zuckerberg, DDS, FAGD, to Board of Advisors

Renowned dental innovator joins Prahsys to accelerate AI imaging innovation and advance clinical technology purpose-built for dental practices.

The Woodlands, Texas, June 15, 2026 - Prahsys, a healthcare technology company modernizing the technological and clinical infrastructure of dental practices, today announced the appointment of Dr. Edward Zuckerberg, DDS, FAGD, to its Board of Advisors.

‍

Bringing Clinical Credibility to AI-Driven Dentistry

Dr. Zuckerberg brings more than four decades of clinical experience and a reputation as one of dentistry's most recognized early adopters of transformative technology, including digital radiography and AI-driven patient engagement. He consults privately with dental practices and dental and medical technology startups, and his appointment directly supports Prahsys' development of its platform. Dr. Zuckerberg will be a key contributor for the Prahsys platform including its agentic AI solutions and predictive PrognosiX AI. 

Notably, the technology-forward environment Dr. Zuckerberg cultivated in his own dental practice helped inspire his son Mark Zuckerberg's early interest in computers, ultimately leading to the creation of Facebook.

"When dentists have greater clarity in what they're seeing, everything improves; their confidence, their recommendations, and their patients' willingness to move forward with treatment," said Dr. Zuckerberg. "Tools like PrognosiX have the potential to meaningfully improve diagnostic precision, which translates directly into better patient care, higher case acceptance, and stronger practice revenue. I'm excited to help Prahsys bring that kind of impact to dental practices." 

Dr. Zuckerberg's clinical expertise and deep practitioner network position him as a key voice in guiding the platform and PrognosiX toward real-world adoption, helping ensure the technology reflects how dentists think, diagnose, and deliver care. His longstanding advocacy for intuitive tools and oral-systemic health aligns with Prahsys' vision of equipping dental practices with smarter tools so they can focus on delivering higher quality care.

Prahsys is developing a platform of purpose-built products for dental practices, consolidating the tools a practice needs into one platform and one login. An expanding suite of agentic AI handles everyday administrative tasks, while vision AI enhances x-ray clinical analysis and patient case acceptance. Dr. Zuckerberg's appointment reflects the company's commitment to ensuring the platform is shaped by deep clinical expertise at every stage of development.

"Everything we build starts with the practice and the patient," said Grey Bonin, CEO of Prahsys. "Having Dr. Zuckerberg alongside us as we develop our platform means we're building with the insight of someone who has spent decades at the cutting edge of dental technology."

About Prahsys

Prahsys Inc. is a healthcare technology company building a unified platform that consolidates the tools dental practices need to operate. Built atop its own proprietary payment rails and combining agentic AI, vision AI, and intuitive design, Prahsys helps providers reduce administrative burden, improve case acceptance, and focus on delivering higher quality care while optimizing business performance. Headquartered in The Woodlands, Texas, Prahsys serves practitioners, dental service organizations, imaging companies, and practice management software providers.

PrognosiX is currently in development. Pending FDA Clearance. Not for Sale.